Cargando…

Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension

Inflammation and altered immunity are recognized components of severe pulmonary arterial hypertension in human patients and in animal models of PAH. While eicosanoid metabolites of cyclooxygenase and lipoxygenase pathways have been identified in the lungs from pulmonary hypertensive animals their ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Husseini, Aysar, Wijesinghe, Dayanjan S., Farkas, Laszlo, Kraskauskas, Donatas, Drake, Jennifer I., Van Tassel, Ben, Abbate, Antonio, Chalfant, Charles E., Voelkel, Norbert F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364907/ https://www.ncbi.nlm.nih.gov/pubmed/25785937 http://dx.doi.org/10.1371/journal.pone.0120157

Ejemplares similares

Sugen, hypoxia and the lung circulation
por: Voelkel, Norbert F., et al.
Publicado: (2021)

CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit(+) Cells in Rats
por: Farkas, Daniela, et al.
Publicado: (2014)

Severe pulmonary hypertension: The role of metabolic and endocrine disorders
por: Bogaard, Harm J., et al.
Publicado: (2012)

Sugen–morphine model of pulmonary arterial hypertension
por: Agarwal, Stuti, et al.
Publicado: (2020)

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
por: Link, Patrick A., et al.
Publicado: (2023)

Copper Deficiency Induced Emphysema Is Associated with Focal Adhesion Kinase Inactivation
por: Mizuno, Shiro, et al.
Publicado: (2012)

Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension
por: Philip, Nicolas, et al.
Publicado: (2023)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis
por: Nicolls, Mark R., et al.
Publicado: (2012)

Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts
por: Wijesinghe, Dayanjan S., et al.
Publicado: (2014)

Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)

IL‐33/ST2 receptor‐dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice
por: Indralingam, Cynthia S., et al.
Publicado: (2022)

Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat
por: Docherty, Craig K., et al.
Publicado: (2020)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents
por: Chen, Tianji, et al.
Publicado: (2022)

Nonvesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids
por: Simanshu, Dhirendra K., et al.
Publicado: (2013)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

The selective PGI(2) receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats
por: Honda, Yohei, et al.
Publicado: (2020)

The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension
por: McNeill, Jenna N., et al.
Publicado: (2023)

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
por: Tornling, Göran, et al.
Publicado: (2023)

Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia‐induced pulmonary hypertension
por: Neto‐Neves, Evandro M., et al.
Publicado: (2017)

Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen–hypoxia rat model by cardiac magnetic resonance imaging
por: Jayasekera, Geeshath, et al.
Publicado: (2020)

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still “the One:” A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman
por: Bogaard, Harm J., et al.
Publicado: (2020)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

SCUBE Diving: Biomarker Discovery for Pulmonary Hypertension From Bench to Bedside
por: Gomez-Arroyo, Jose, et al.
Publicado: (2020)

Acrolein Induces Endoplasmic Reticulum Stress and Causes Airspace Enlargement
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2012)

Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate
por: Yasuo, Masanori, et al.
Publicado: (2013)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together
por: Gomez-Arroyo, Jose, et al.
Publicado: (2017)

MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension
por: Faight, Erin M., et al.
Publicado: (2017)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

Ceramide Kinase Regulates the Production of Tumor Necrosis Factor α (TNFα) via Inhibition of TNFα-converting Enzyme
por: Lamour, Nadia F., et al.
Publicado: (2011)

Structural Stereochemistry of Androstene Hormones Determines Interactions with Human Androgen, Estrogen, and Glucocorticoid Receptors
por: Shaak, Thomas L., et al.
Publicado: (2013)

Antihypertensive Treatment Differentially Affects Vascular Sphingolipid Biology in Spontaneously Hypertensive Rats
por: Spijkers, Léon J. A., et al.
Publicado: (2011)

Massive dilatation of the pulmonary artery in association with pulmonic stenosis and pulmonary hypertension
por: Morjaria, Sejal, et al.
Publicado: (2012)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
por: Sakao, Seiichiro, et al.
Publicado: (2014)

Cytochrome P450 eicosanoids in hypertension and renal disease
por: Fan, Fan, et al.
Publicado: (2015)

Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension
por: Sweeney, Lori, et al.
Publicado: (2009)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8tmsp027np6pl16ifpd7q4p0mr